» Articles » PMID: 18350548

Viruses Induce High Expression of BAFF by Salivary Gland Epithelial Cells Through TLR- and Type-I IFN-dependent and -independent Pathways

Overview
Journal Eur J Immunol
Date 2008 Mar 20
PMID 18350548
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

B cell activating factor (BAFF) plays a key role in promoting B lymphocyte activation. We investigated whether danger signals induce BAFF secretion by cultured salivary gland epithelial cells (SGEC), which are the target of primary Sjögren's syndrome, a prototypic systemic autoimmune disease. SGEC cultures were established from minor salivary glands obtained from ten patients with pSS or sicca symptoms. BAFF mRNA and protein were measured after stimulation of the different Toll-like receptors (TLR) by agonists or viruses. The expression of TLR2, -3, and -7 was detected in SGEC. Poly (I:C) (a synthetic TLR3 agonist) and reovirus-1 (a dsRNA virus) induced high expression of BAFF mRNA (multiplied by a factor of 246 +/- 39 (SEM) and 347 +/- 66, respectively) and of BAFF protein secretion (58.49 +/- 4.34 pg/mL and 69.73 +/- 5.67). Inhibition of both the endosomal (by chloroquine) and IFN (by anti-IFNAR antibody) pathways partly inhibited BAFF expression. Treatment with both dsRNA virus and poly (I:C) induced high levels of BAFF mRNA and protein expression by SGEC, through pathways dependent on and independent of TLR and dependent on and independent of IFN. BAFF induction by target organs of autoimmune diseases after viral infection may be a link between innate immunity and autoimmunity.

Citing Articles

Toll-like receptor 3: a double-edged sword.

Hsieh M, Nishizaki D, Adashek J, Kato S, Kurzrock R Biomark Res. 2025; 13(1):32.

PMID: 39988665 PMC: 11849352. DOI: 10.1186/s40364-025-00739-5.


The role of cytokines from salivary gland epithelial cells in the immunopathology of Sjögren's syndrome.

Dong Y, Wang T, Wu H Front Immunol. 2024; 15:1443455.

PMID: 39346911 PMC: 11427401. DOI: 10.3389/fimmu.2024.1443455.


Identification and verification of inflammatory biomarkers for primary Sjögren's syndrome.

Liu X, Wang H, Wang X, Jiang X, Jin Y, Han Y Clin Rheumatol. 2024; 43(4):1335-1352.

PMID: 38376769 PMC: 10944815. DOI: 10.1007/s10067-024-06901-y.


Current Views on Pathophysiology and Potential Therapeutic Targets in Sjögren's Syndrome: A Review from the Perspective of Viral Infections, Toll-like Receptors, and Long-Noncoding RNAs.

Horai Y, Shimizu T, Umeda M, Nishihata S, Nakamura H, Kawakami A J Clin Med. 2023; 12(18).

PMID: 37762814 PMC: 10531551. DOI: 10.3390/jcm12185873.


The Role of Regulatory T Cells in the Onset and Progression of Primary Sjögren's Syndrome.

Blinova V, Vasilyev V, Rodionova E, Zhdanov D Cells. 2023; 12(10).

PMID: 37408193 PMC: 10216593. DOI: 10.3390/cells12101359.